BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37953462)

  • 21. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
    Qin S; Mao Y; Chen X; Xiao J; Qin Y; Zhao L
    Int J Biol Sci; 2021; 17(12):3059-3079. PubMed ID: 34421350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness.
    Bi L; Ren Y; Feng M; Meng P; Wang Q; Chen W; Jiao Q; Wang Y; Du L; Zhou F; Jiang Y; Chen F; Wang C; Tang B; Wang Y
    Cancer Res; 2021 Apr; 81(8):2015-2028. PubMed ID: 33602787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.
    Liu Z; Yu Y; Huang Z; Kong Y; Hu X; Xiao W; Quan J; Fan X
    Cell Death Dis; 2019 Nov; 10(12):900. PubMed ID: 31776329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism-induced tumor activator 1 (MITA1), an Energy Stress-Inducible Long Noncoding RNA, Promotes Hepatocellular Carcinoma Metastasis.
    Ma M; Xu H; Liu G; Wu J; Li C; Wang X; Zhang S; Xu H; Ju S; Cheng W; Dai L; Wei Y; Tian Y; Fu X
    Hepatology; 2019 Jul; 70(1):215-230. PubMed ID: 30839115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CircCPSF6 promotes hepatocellular carcinoma cancer progression by regulating MAP4K4 through sponging miR-145-5p.
    Lu F; Gao J; Luo Y; Jin WL; Wang H; Li CX; Li X
    Mol Cell Probes; 2023 Oct; 71():101920. PubMed ID: 37442529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Novel RNA Binding Proteins Influencing Circular RNA Expression in Hepatocellular Carcinoma.
    Razpotnik R; Nassib P; Kunej T; Rozman D; Režen T
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput circular RNA sequencing reveals the profiles of circular RNA in non-cirrhotic hepatocellular carcinoma.
    Li H; Xu L; Yi P; Li L; Yan T; Xie L; Zhu Z
    BMC Cancer; 2022 Aug; 22(1):857. PubMed ID: 35931993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hippocalcin-Like 1 blunts liver lipid metabolism to suppress tumorigenesis via directly targeting RUVBL1-mTOR signaling.
    Chen T; Yuan Z; Lei Z; Duan J; Xue J; Lu T; Yan G; Zhang L; Liu Y; Li Q; Zhang Y
    Theranostics; 2022; 12(17):7450-7464. PubMed ID: 36438486
    [No Abstract]   [Full Text] [Related]  

  • 30. Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma.
    Luo Z; Mao X; Cui W
    Med Oncol; 2019 Sep; 36(10):86. PubMed ID: 31494761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CircRNA circ-0038718 promotes hepatocellular carcinoma progression through sponging miR-139-3p.
    Sun R; Li H; Li J; Shen S; Cui G; Dong G
    Biochem Biophys Res Commun; 2020 Dec; 533(4):845-852. PubMed ID: 33008587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
    Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
    Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening Linear and Circular RNA Transcripts from Stress Granules.
    Chen S; Zhang J; Zhao F
    Genomics Proteomics Bioinformatics; 2023 Aug; 21(4):886-893. PubMed ID: 35085777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of RNA binding protein interacting with circular RNA and hub candidate network for hepatocellular carcinoma.
    Cheng B; Tian J; Chen Y
    Aging (Albany NY); 2021 Jun; 13(12):16124-16143. PubMed ID: 34133325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling.
    Gu Y; Wang Y; He L; Zhang J; Zhu X; Liu N; Wang J; Lu T; He L; Tian Y; Fan Z
    Mol Cancer; 2021 Oct; 20(1):132. PubMed ID: 34649567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.
    Hu Z; Chen G; Zhao Y; Gao H; Li L; Yin Y; Jiang J; Wang L; Mang Y; Gao Y; Zhang S; Ran J; Li L
    Mol Cancer; 2023 Mar; 22(1):55. PubMed ID: 36932387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1.
    Xu J; Ji L; Liang Y; Wan Z; Zheng W; Song X; Gorshkov K; Sun Q; Lin H; Zheng X; Chen J; Jin RA; Liang X; Cai X
    Signal Transduct Target Ther; 2020 Dec; 5(1):298. PubMed ID: 33361760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of potentially functional circular RNAs hsa_circ_0070934 and hsa_circ_0004315 as prognostic factors of hepatocellular carcinoma by integrated bioinformatics analysis.
    Morovat P; Morovat S; Ashrafi AM; Teimourian S
    Sci Rep; 2022 Mar; 12(1):4933. PubMed ID: 35322101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
    Su Y; Lv X; Yin W; Zhou L; Hu Y; Zhou A; Qi F
    Aging (Albany NY); 2019 Oct; 11(19):8183-8203. PubMed ID: 31581132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.